Monthly Archives: February 2022

Protecting Inventions Relating to Artificial Intelligence: Best Practices

Protecting Inventions Relating to Artificial Intelligence: Best Practices

By Nicholas Evans| 2022-02-25T17:17:42-05:00 February 25th, 2022|IPO Law Journal|Comments Off

Read More

IPO and AIPLA Joint Letter Urging Confirmation of the USPTO Director Nominee Kathi Vidal

IPO and AIPLA Joint Letter Urging Confirmation of the USPTO [...]

By Hannah Denny| 2022-02-28T08:18:02-05:00 February 24th, 2022|Testimony and Comments|Comments Off

Read More

IPO Comments Regarding the USPTO’s Notice of Proposed Rulemaking on Electronic Patent Issuance

IPO Comments Regarding the USPTO’s Notice of Proposed Rulemaking on [...]

By Hannah Denny| 2022-02-15T10:18:18-05:00 February 14th, 2022|Testimony and Comments|Comments Off

Read More

“Unofficial” CN Orange Book User Guide for Pharmaceutical Patents

“Unofficial” CN Orange Book User Guide for Pharmaceutical Patents

By Nicholas Evans| 2022-02-11T15:13:09-05:00 February 11th, 2022|IPO Law Journal, Patents|Comments Off

Read More

A First Look at the FDA’s Proposed Regulatory Framework for Modifications to AI-Based Software as a Medical Device (SaMD): IP Review and Strategy Guide

A First Look at the FDA’s Proposed Regulatory Framework for [...]

By Nicholas Evans| 2022-02-07T18:15:45-05:00 February 7th, 2022|IPO Law Journal|Comments Off

Read More